Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D and Reduction of Breast Cancer Risk

  • Risk, Prevention, and Screening (TA Patel, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Vitamin D is not only essential in bone metabolism and calcium homeostasis but also has anticarcinogenic properties in multiple malignancies, including breast cancer. Vitamin D deficiency is a potentially modifiable risk factor that may be easily targeted for breast cancer risk reduction through supplementation. Several epidemiological studies have demonstrated an inverse relationship between dietary intake and blood levels of vitamin D and breast cancer risk; however, the results have been inconsistent. Despite some promising findings, further randomized controlled trials of vitamin D supplements are needed to determine the role of vitamin D in breast cancer prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.

    Article  PubMed  Google Scholar 

  2. Jemal A et al. Global cancer statistics. Ca-a Cancer J Clin. 2011;61(2):69–90.

    Article  Google Scholar 

  3. Studzinski GP, Moore DC. Sunlight—can it prevent as well as cause cancer? Cancer Res. 1995;55(18):4014–22.

    CAS  PubMed  Google Scholar 

  4. Gorham ED, Garland FC, Garland CF. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol. 1990;19(4):820–4.

    Article  CAS  PubMed  Google Scholar 

  5. Garland FC et al. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990;19(6):614–22.

    Article  CAS  PubMed  Google Scholar 

  6. Blot WJ, Fraumeni Jr JF, Stone BJ. Geographic patterns of breast cancer in the United States. J Natl Cancer Inst. 1977;59(5):1407–11.

    CAS  PubMed  Google Scholar 

  7. Welsh J. Vitamin D and breast cancer: insights from animal models. Am J Clin Nutr. 2004;80(6 Suppl):1721S–4S.

    CAS  PubMed  Google Scholar 

  8. Looker AC et al. Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr. 2008;88(6):1519–27.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Wortsman J et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–3.

    CAS  PubMed  Google Scholar 

  10. Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2008;624:31–42.

    Article  CAS  PubMed  Google Scholar 

  11. Hewison M et al. 1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol. 2000;25(2):141–8.

    Article  CAS  PubMed  Google Scholar 

  12. Schwartz GG et al. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev. 1998;7(5):391–5.

    CAS  PubMed  Google Scholar 

  13. Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 2006;26(4A):2637–45.

    CAS  PubMed  Google Scholar 

  14. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002;9(1):45–59.

    Article  CAS  PubMed  Google Scholar 

  15. Feldman D et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–57. A review article that explores the anti-malignant properties and mechanisms of action of vitamin D and its potential role in prevention in multiple cancers.

    Article  CAS  PubMed  Google Scholar 

  16. Abbas S, Linseisen J, Chang-Claude J. Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study. Nutr Cancer. 2007;59(1):54–61.

    Article  CAS  PubMed  Google Scholar 

  17. Levi F et al. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer. 2001;91(2):260–3.

    Article  CAS  PubMed  Google Scholar 

  18. Potischman N et al. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer. 1999;82(3):315–21.

    Article  CAS  PubMed  Google Scholar 

  19. Rossi M et al. Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol. 2009;20(2):374–8.

    Article  CAS  PubMed  Google Scholar 

  20. Simard A, Vobecky J, Vobecky JS. Vitamin D deficiency and cancer of the breast: an unprovocative ecological hypothesis. Can J Public Health. 1991;82(5):300–3.

    CAS  PubMed  Google Scholar 

  21. Frazier AL et al. Adolescent diet and risk of breast cancer. Cancer Causes Control. 2004;15(1):73–82.

  22. John EM, Vitamin D, et al. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999;8(5):399–406.

    CAS  PubMed  Google Scholar 

  23. Lin J et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med. 2007;167(10):1050–9.

    Article  CAS  PubMed  Google Scholar 

  24. McCullough ML et al. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2898–904.

    Article  CAS  PubMed  Google Scholar 

  25. Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women’s Health Study. Cancer Causes Control. 2007;18(7):775–82.

    Article  PubMed  Google Scholar 

  26. Shin MH et al. Intake of dairy products, calcium, and vitamin d and risk of breast cancer. J Natl Cancer Inst. 2002;94(17):1301–11.

    Article  CAS  PubMed  Google Scholar 

  27. Chen P et al. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010;121(2):469–77.

    Article  CAS  PubMed  Google Scholar 

  28. Frazier AL et al. Adolescent diet and risk of breast cancer. Cancer Causes Control. 2004;15(1):73–82.

    Article  PubMed  Google Scholar 

  29. Kuper H et al. Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2558–61.

    Article  CAS  PubMed  Google Scholar 

  30. Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Cancer. 2010;46(14):2555–62.

    Article  PubMed  Google Scholar 

  31. Edvardsen K et al. Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk. Int J Cancer. 2011;128(6):1425–33.

    Article  CAS  PubMed  Google Scholar 

  32. Abbas S et al. Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Nutr Cancer. 2013;65(2):178–87.

    Article  CAS  PubMed  Google Scholar 

  33. Kim Y, Je Y. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer. 2014;110(11):2772–84. A recent meta-analysis restricted to only prospective cohort studies that explores both the relationship of vitamin D intake and 25-hydroxyvitamin D serum levels with breast cancer risk.

    Article  CAS  PubMed  Google Scholar 

  34. Ross AC et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. World Health Organization. Prevention and management of osteoporosis. World Health Organization Technical Report Series. 2003;921:1–164.

  36. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr. 2008;87(4):1087S–91S.

    CAS  PubMed  Google Scholar 

  37. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–8.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Crew KD et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila). 2009;2(6):598–604.

    Article  CAS  Google Scholar 

  39. Garland CF et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol. 2007;103(3–5):708–11.

    Article  CAS  PubMed  Google Scholar 

  40. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2009;124(1):250–5.

    Article  CAS  PubMed  Google Scholar 

  41. Abbas S et al. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case-control study. Carcinogenesis. 2008;29(1):93–9.

    Article  CAS  PubMed  Google Scholar 

  42. Freedman DM et al. Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008;17(4):889–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. McCullough ML et al. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast Cancer Res. 2009;11(4):R64.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Rejnmark L et al. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2655–60.

    Article  CAS  PubMed  Google Scholar 

  45. Engel P et al. Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2341–50.

    Article  CAS  PubMed  Google Scholar 

  46. Wang D et al. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies. Tumour Biol. 2013;34(6):3509–17.

    Article  CAS  PubMed  Google Scholar 

  47. Ordonez-Mena JM et al. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2013;22(5):905–16.

    Article  CAS  PubMed  Google Scholar 

  48. Kuhn T et al. Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study. Int J Cancer. 2013;133(7):1689–700.

    Article  PubMed  Google Scholar 

  49. Mohr SB et al. Serum 25-hydroxyvitamin D and breast cancer in the military: a case-control study utilizing pre-diagnostic serum. Cancer Causes Control. 2013;24(3):495–504.

    Article  PubMed  Google Scholar 

  50. Scarmo S et al. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res. 2013;15(1):R15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  51. Almquist M et al. Serum levels of vitamin D, PTH and calcium and breast cancer risk—a prospective nested case-control study. Int J Cancer. 2010;127(9):2159–68.

    Article  CAS  PubMed  Google Scholar 

  52. Skaaby T et al. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1220–9.

    Article  CAS  PubMed  Google Scholar 

  53. Xie SP, Pirianov G, Colston KW. Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells. Eur J Cancer. 1999;35(12):1717–23.

    Article  CAS  PubMed  Google Scholar 

  54. Colston KW et al. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol. 1998;20(1):157–62.

    Article  CAS  PubMed  Google Scholar 

  55. Bezemer ID et al. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 2005;16(5):561–72.

    Article  PubMed  Google Scholar 

  56. Lukanova A et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150(2):161–71.

    Article  CAS  PubMed  Google Scholar 

  57. Chen WY et al. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14(10):2335–9.

    Article  CAS  PubMed  Google Scholar 

  58. Guy M et al. Vitamin D receptor gene polymorphisms and breast cancer risk. Clin Cancer Res. 2004;10(16):5472–81.

    Article  CAS  PubMed  Google Scholar 

  59. Uitterlinden AG et al. Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states. J Steroid Biochem Mol Biol. 2004;89–90(1–5):187–93.

    Article  PubMed  Google Scholar 

  60. Buyru N et al. Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med. 2003;35(6):550–5.

    Article  CAS  PubMed  Google Scholar 

  61. Bretherton-Watt D et al. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer. 2001;85(2):171–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Ingles SA et al. Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control. 2000;11(1):25–30.

    Article  CAS  PubMed  Google Scholar 

  63. Curran JE et al. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999;83(6):723–6.

    Article  CAS  PubMed  Google Scholar 

  64. John EM et al. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007;166(12):1409–19.

    Article  PubMed  Google Scholar 

  65. McCullough ML et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res. 2007;9(1):R9.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Guy M et al. Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk. Recent Results Cancer Res. 2003;164:43–54.

    Article  CAS  PubMed  Google Scholar 

  67. Durrin LK et al. Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability. Biochim Biophys Acta. 1999;1453(3):311–20.

    Article  CAS  PubMed  Google Scholar 

  68. Whitfield GK et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177(1–2):145–59.

    Article  CAS  PubMed  Google Scholar 

  69. Trabert B et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case–control study of Caucasian and African-American women. Breast Cancer Res. 2007;9(6):R84.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Ruggiero M et al. Vitamin D receptor gene polymorphism is associated with metastatic breast cancer. Oncol Res. 1998;10(1):43–6.

    CAS  PubMed  Google Scholar 

  71. Afzal S et al. Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ. 2014;349:g6330. Recent study using Mendelian randomization to examine the effect of genetically driven vitamin D concentration on cancer mortality.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Ahn J et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19(13):2739–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. Wang TJ et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  74. Abbas S et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev. 2008;17(6):1339–43.

    Article  CAS  PubMed  Google Scholar 

  75. Reimers LL, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015;26(2):187–203.

  76. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88(2):582S–6S.

    CAS  PubMed  Google Scholar 

  77. Lappe JM et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586–91.

    CAS  PubMed  Google Scholar 

  78. Chlebowski RT et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100(22):1581–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  79. Wactawski-Wende J et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684–96.

    Article  CAS  PubMed  Google Scholar 

  80. Manson JE et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Boyd NF et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798–808.

    Article  PubMed  Google Scholar 

  82. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159–69.

    Article  PubMed  Google Scholar 

  83. Brisson J et al. Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev. 2007;16(5):929–33.

    Article  CAS  PubMed  Google Scholar 

  84. Berube S et al. Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1653–9.

    Article  CAS  PubMed  Google Scholar 

  85. Diorio C et al. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res. 2006;66(1):588–97.

    Article  CAS  PubMed  Google Scholar 

  86. Colangelo LA et al. A pilot study of vitamin D, calcium, and percent breast density in Hispanic women. Nutr Res. 2006;26(1):11–5.

    Article  CAS  Google Scholar 

  87. Crew KD et al. Mammographic density and serum 25-hydroxyvitamin D levels. Nutr Metab (Lond). 2014;11:18.

    Article  Google Scholar 

  88. Knight JA et al. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomark Prev. 2006;15(10):1988–92.

    Article  CAS  Google Scholar 

  89. Green AK et al. Mammographic density, plasma vitamin D levels and risk of breast cancer in postmenopausal women. Int J Cancer. 2010;127(3):667–74.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  90. Chai W, Maskarinec G, Cooney RV. Serum 25-hydroxyvitamin D levels and mammographic density among premenopausal women in a multiethnic population. Eur J Clin Nutr. 2010;64(6):652–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  91. Neuhouser ML et al. Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2010;19(2):412–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  92. Crew KD et al. Safety, feasibility, and biomarker effects of high-dose Vitamin D supplementation among women at high risk for breast cancer. Int J Food Sci Nutr Diet. 2015;S1(100):1–9.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Jennifer K. Lue and Katherine D. Crew declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Hematology/Oncology, College of Physicians and Surgeons, Columbia University, New York, NY, USA

    Jennifer K. Lue & Katherine D. Crew

  2. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA

    Katherine D. Crew

  3. Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Fort Washington Ave, 10-1072, New York, NY, 10032, USA

    Katherine D. Crew

Authors
  1. Jennifer K. Lue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine D. Crew
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine D. Crew.

Additional information

This article is part of the Topical Collection on Risk, Prevention, and Screening

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lue, J.K., Crew, K.D. Vitamin D and Reduction of Breast Cancer Risk. Curr Breast Cancer Rep 7, 90–97 (2015). https://doi.org/10.1007/s12609-015-0180-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-015-0180-5

Keywords

Search

Navigation